Long-Term Outcomes of Acute Myocardial Infarction in Patients With Hypertrophic Cardiomyopathy

Angiology
Fang LiuYujie Zhou

Abstract

Hypertrophic cardiomyopathy (HCM) is associated with poor prognosis. It has been reported that there is no difference in in-hospital mortality after acute myocardial infarction (AMI) between patients with and without HCM. However, whether there are differences in long-term outcomes after AMI between patients with and without HCM remains unclear. In this study, we analyzed the clinical profiles of 78 consecutive patients with HCM and AMI (HCM and AMI group), 78 sex- and age-matched patients with AMI and without HCM (AMI group), and 78 sex- and age-matched patients with HCM and without AMI (HCM group). The study end points were major adverse cardiac events (MACEs) and secondary end points. During the follow-up period of 4.8 ± 3.6 years, MACEs occurred in 19 (27.9) patients in the HCM and AMI group, in 11 (16.7%) patients in the AMI group, and in 8 (12.3%) patients in the HCM group. The long-term outcomes of the HCM and AMI group were inferior to that of the other 2 groups (log-rank P = .030 for MACEs, log-rank P = .032 for secondary end points). In conclusion, patients with AMI with HCM exhibited worse long-term outcomes than did patients with AMI without HCM and patients with HCM without AMI.

References

Jul 1, 1976·The American Journal of Cardiology·A Walston, V S Behar
Aug 1, 1991·Stroke; a Journal of Cerebral Circulation·P A WolfW B Kannel
Nov 4, 1991·The American Journal of Cardiology·P K Shah, J S Forrester
Sep 1, 1986·Journal of the American College of Cardiology·B J MaronW C Roberts
May 1, 1985·The American Journal of Cardiology·D V CokkinosR D Leachman
Oct 1, 1995·Circulation·E D WigleW G Williams
Sep 1, 1996·Journal of the American College of Cardiology·P KaufmannO M Hess
Oct 22, 1998·The New England Journal of Medicine·A T YetmanR Gow
Feb 26, 2000·The New England Journal of Medicine·F GoriG Thiene
Mar 12, 2002·JAMA : the Journal of the American Medical Association·Barry J Maron
Nov 28, 2002·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Katsushi MisawaHiroshi Mabuchi
Sep 12, 2003·The New England Journal of Medicine·Franco CecchiPaolo G Camici
Jan 7, 2004·The American Journal of Medicine·Barry J Maron
May 10, 2005·Stroke; a Journal of Cerebral Circulation·Carmine MariniAntonio Carolei
Oct 6, 2005·European Heart Journal·Robby NieuwlaatUNKNOWN European Heart Survey Investigators
Aug 12, 2008·The Journal of Thoracic and Cardiovascular Surgery·Allan Stewart
Aug 22, 2009·Journal of the American College of Cardiology·Martin S MaronPaolo G Camici
Jul 21, 2011·Circulation. Cardiovascular Quality and Outcomes·Suzanne V ArnoldUNKNOWN Cardiovascular Outcomes Research Consortium
Aug 10, 2012·Lancet·Barry J Maron, Martin S Maron
Aug 28, 2012·Circulation·Kristian ThygesenShanti Mendis
Jul 7, 2014·Journal of the American College of Cardiology·Barry J MaronMartin S Maron
Apr 26, 2015·The American Journal of Medicine·Tanush GuptaJulio A Panza

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass

Software Mentioned

GraphPad Prism
SPSS
GraphPad

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.